How to buy 89bio stock | $17.39

89bio Inc is a biotechnology business based in the US. 89bio shares (ETNB) are listed on the NASDAQ and all prices are listed in US Dollars. 89bio employs 26 staff and has a market cap (total outstanding shares value) of 0.00.

89bio stock price (NASDAQ: ETNB)

Use our graph to track the performance of ETNB stocks over time.

89bio shares at a glance

• Key figures

Information last updated 2021-10-16.

Latest market close	$17.39
52-week range	$14.70 - $28.28
50-day moving average	$19.45
200-day moving average	$20.19
Wall St. target price	$52.00
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	$-3.27

Buy 89bio shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy 89bio stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

89bio price performance over time

Historical closes compared with the close of $17.39 from 2021-10-20

1 week (2021-10-14)	-3.17%
1 month (2021-09-21)	-14.25%
3 months (2021-07-21)	-0.57%
6 months (2021-04-21)	-37.89%

1 year (2020-10-21)	-26.56%
2 years (2019-10-17)	N/A
3 years (2018-10-17)	N/A
5 years (2016-10-17)	N/A

89bio financials

Gross profit TTM	$0
Return on assets TTM	-30.14%
Return on equity TTM	-51.71%
Profit margin	0%
Book value	$8.60
Market capitalisation	$363 million

TTM: trailing 12 months

Shorting 89bio shares

There are currently 936,055 89bio shares held short by investors – that's known as 89bio's "short interest". This figure is 0.3% down from 938,858 last month.

There are a few different ways that this level of interest in shorting 89bio shares can be evaluated.

89bio's "short interest ratio" (SIR)

89bio's "short interest ratio" (SIR) is the quantity of 89bio shares currently shorted divided by the average quantity of 89bio shares traded daily (recently around 87400.093370682). 89bio's SIR currently stands at 10.71. In other words for every 100,000 89bio shares traded daily on the market, roughly 10710 shares are currently held short.

However 89bio's short interest can also be evaluated against the total number of 89bio shares, or, against the total number of tradable 89bio shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case 89bio's short interest could be expressed as 0.05% of the outstanding shares (for every 100,000 89bio shares in existence, roughly 50 shares are currently held short) or 0.1113% of the tradable shares (for every 100,000 tradable 89bio shares, roughly 111 shares are currently held short).

A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against 89bio.

Find out more about how you can short 89bio stock.

89bio share dividends

We're not expecting 89bio to pay a dividend over the next 12 months.

89bio overview

89bio, Inc. , a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is BIO89-100, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also intends to develop BIO89-100 for the treatment of severe hypertriglyceridemia. 89bio, Inc. was founded in 2018 and is based in San Francisco, California. .

Frequently asked questions

What percentage of 89bio is owned by insiders or institutions?
Currently 1.13% of 89bio shares are held by insiders and 99.253% by institutions. How many people work for 89bio?
Latest data suggests 26 work at 89bio. When does the fiscal year end for 89bio?
89bio's fiscal year ends in December. Where is 89bio based?
89bio's address is: 142 Sansome Street, San Francisco, CA, United States, 94104 What is 89bio's ISIN number?
89bio's international securities identification number is: US2825591033 What is 89bio's CUSIP number?
89bio's Committee on Uniform Securities Identification Procedures number is: 282559103